Cargando…
The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine
During its clinical development fialuridine caused liver toxicity and the death of five patients. This case remains relevant due to the continued development of mechanistically-related compounds against a back-drop of simple in vitro models which remain limited for the preclinical detection of such...
Autores principales: | Jolly, Carol E., Douglas, Oisin, Kamalian, Laleh, Jenkins, Rosalind E., Beckett, Alison J., Penman, Sophie L., Williams, Dominic P., Monshouwer, Mario, Simic, Damir, Snoeys, Jan, Park, B. Kevin, Chadwick, Amy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456776/ https://www.ncbi.nlm.nih.gov/pubmed/32730777 http://dx.doi.org/10.1016/j.taap.2020.115163 |
Ejemplares similares
-
Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells
por: Penman, Sophie L., et al.
Publicado: (2019) -
Evaluation of the impact of matrix stiffness on encapsulated HepaRG spheroids
por: Rebelo, Sofia P, et al.
Publicado: (2013) -
Evaluation of a novel PXR‐knockout in HepaRG(™) cells
por: Williamson, Beth, et al.
Publicado: (2016) -
Active Transport of Hepatotoxic Pyrrolizidine Alkaloids in HepaRG Cells
por: Enge, Anne-Margarethe, et al.
Publicado: (2021) -
Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells
por: Dubois-Pot-Schneider, Hélène, et al.
Publicado: (2022)